Musings from The Power List: Ali Tavassoli
Ali Tavassoli explains how cyclic peptides and new discovery tools are opening up once-inaccessible biology
False
Ali Tavassoli explains how cyclic peptides and new discovery tools are opening up once-inaccessible biology
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
False
False
October 22, 2026
5 min read
Rob DiCicco discusses how FDA–industry collaboration is helping sponsors rethink safety reporting, selective safety data collection, and pragmatic clinical trial design.
October 22, 2026
5 min read
Alcami’s Kerrie Powell, Senior VP of Sales, discusses the challenges of sterile biologics manufacturing and what sponsors should look for in a CDMO partner
October 22, 2026
5 min read
Stevanato Group’s Adam Stops discusses how delivery systems and manufacturing capabilities can keep pace with increasingly complex drug formulations
October 21, 2026
6 min read
Bristol Myers Squibb’s Robert Wethman discusses real-time spectroscopy, AI, and the next era of biopharmaceutical manufacturing
False
Affiliations:
Specialties:
Areas of Expertise: